Latest News
Agilent launches S540MD slide scanner system in US
4 September 2026 - Agilent Technologies Inc (NYSE:A), a provider of analytical and clinical laboratory technologies, on Friday launched the Agilent S540MD Slide Scanner System in the United States following FDA clearance, expanding its digital pathol...
Immuron signs US distribution deal for PROIBS
4 September 2026 - Australian biopharmaceutical company Immuron Limited (ASX: IMC; NASDAQ: IMRN), which develops and commercialises targeted polyclonal antibodies for infectious diseases, announced on Friday that it has signed an exclusive US distrib...
Cipla partners with Qilu Pharmaceutical for licensing and supply of Keytruda biosimilar in US
4 September 2026 - Invagen Pharmaceuticals Inc, a wholly owned subsidiary of India-based pharmaceutical company Cipla Limited (BSE:500087) (NSE:CIPLA), announced on Thursday that it has entered into a strategic partnership with China-based Qilu Pharm...
Cepheid's Xpert Hemorrhagic Fever Panel test granted WHO Emergency Use Listing to support DRC Ebola outbreak response
4 September 2026 - Molecular diagnostics company Cepheid, a Danaher (NYSE:DHR) company, announced on Thursday that it has received Emergency Use Listing (EUL) from the World Health Organization (WHO) for the Xpert Hemorrhagic Fever Panel test to supp...
Kali Therapeutics' KT501 Investigational New Drug application cleared by US FDA
4 September 2026 - Kali Therapeutics, a clinical-stage biotechnology company focused on new therapies for autoimmune and inflammatory diseases, announced on Thursday that the US Food and Drug Administration (FDA) has cleared the company's Invest...